Today, the central nervous system faces unprecedented public health challenges. Our mission focuses on two major pillars where unmet needs remain immense: neuro-oncology (particularly pediatric) and neurodegenerative diseases.

1. Central Nervous System Cancers: Protecting the Future 

Despite medical progress, brain tumors remain a brutal reality, especially among the youngest patients. Today, they are the leading cause of death by disease in children and the second most common pediatric cancer, with an overall mortality rate of 40%. 

Our research focus: Targeting cancer stem cells for destruction. By eliminating these cells, which are at the root of treatment resistance, we aim to neutralize the very source of tumor recurrence. 

2. Neurological Diseases: Facing a Chronic Urgency 

An aging population coupled with environmental factors is currently causing an explosion in brain pathologies. Parkinson's disease illustrates this trend with a staggering 145% increase in incidence over just thirty years. This urgency also concerns multiple sclerosis, with a diagnosis rate now reaching one every four hours in France. Finally, research remains mobilized against Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, a particularly devastating pathology with an average life expectancy of only two to five years.  

Our research focus: Targeting neural stem cells. Our approach consists of stimulating the brain's natural repair and regeneration capabilities to restore lost functions. 

Our Vision

Whether it is destroying malignant stem cells to defeat cancer or mobilizing neural stem cells to repair neurological damage, we place cutting-edge cell biology at the service of patients to meet the greatest challenges of modern neurology.